Zdrowie i gospodarka · 27/05/2009
FDA Releases Draft Guidance on Presenting Risk Information in Prescription Drug and Medical Device Promotion
The Food and Drug Administration (FDA) has released a draft guidance for the pharmaceutical and medical device industries on presenting risk information in promotional materials, responding to stakeholder requests for clearer guidelines.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →